Acute Myeloid Leukemia in Children
1 competing product in clinical development for Acute Myeloid Leukemia in Children.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Quizartinib + Etoposide + Dexrazoxane + Mitoxantrone + Cytarabine + Methotrexate + Daunorubicin + Fludarabine | Daiichi Sankyo | Phase 2 | Recruiting | 42 |